| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |